Jean Jacques Bienaime

Companies

• Ascendis Pharma A/SBoard member Apr 1, 2026 to now⁷
• Keros Therapeutics, Inc.Board member Jun 5, 2024 to now⁸
• Immunome Inc.Board member Nov 9, 2023 to now⁹
• IncyteBoard member Jan 22, 2015 to now¹⁰
• BioMarin PharmaceuticalBoard member Jan 4, 2006 to May 21, 2024¹¹
• BioMarin PharmaceuticalChief executive officer May 2005 to Dec 5, 2023¹²
• IMMUNIC, INC.Board member Apr 16, 2014 to Sep 24, 2018¹³
• BioMarin PharmaceuticalChief Business Officer Feb 14, 2013 to Feb 14, 2013¹⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• BioMarin Pharmaceutical BMRN473,892 shares¹⁵$25.9M at $54.75May 21, 2024
• Incyte INCY24,424 shares¹⁶$2.8M at $113.77Jun 8, 2026
• IImmunome Inc. IMNM43,415 shares¹⁷$723.5K at $16.66Jun 5, 2026
• APAscendis Pharma A/S ASND2,900 shares¹⁸$668.7K at $230.59Aug 14, 2026
• KTKeros Therapeutics, Inc. KROS19,592 shares¹⁹$216.3K at $11.04Aug 17, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 17, 2026Bought 1,000 shares at $10.27 of Keros Therapeutics, Inc.¹⁹
• Aug 14, 2026Bought 900 shares at $246.91 of Ascendis Pharma A/S¹⁸
• Aug 14, 2026Bought 1,100 shares at $245.85 of Ascendis Pharma A/S¹⁸
• Jul 15, 2026Bought 1,000 shares at $10.61 of Keros Therapeutics, Inc.²⁰
• Jun 15, 2026Bought 1,000 shares at $10.19 of Keros Therapeutics, Inc.²¹
• Jun 8, 2026Granted 1,642 shares of Incyte¹⁶
• Jun 5, 2026Bought 1,000 shares at $19.27 of Immunome Inc.¹⁷
• Jun 5, 2026Bought 3,500 shares at $19.46 of Immunome Inc.¹⁷
• Jun 5, 2026Bought 6,000 shares at $19.48 of Immunome Inc.¹⁷
• Jun 5, 2026Sold 10,000 shares at $19.41 of Immunome Inc.¹⁷
• Jun 5, 2026Sold 500 shares at $19.44 of Immunome Inc.¹⁷
• Jun 3, 2026Granted 7,142 shares of Keros Therapeutics, Inc.²²
• May 29, 2026Bought 100 shares at $223.50 of Ascendis Pharma A/S²³
• May 29, 2026Bought 200 shares at $222.30 of Ascendis Pharma A/S²³
• May 29, 2026Bought 200 shares at $223.76 of Ascendis Pharma A/S²³
• May 26, 2026Shares withheld for tax 13,059 shares at $97.10 of Incyte²⁴
• May 26, 2026Bought 200 shares at $239.37 of Ascendis Pharma A/S²⁵
• May 26, 2026Exercised options 15,000 shares at $84.53 of Incyte²⁴
• May 26, 2026Bought 200 shares at $236.24 of Ascendis Pharma A/S²⁵
• May 15, 2026Bought 5,000 shares at $20.70 of Immunome Inc.²⁶
• May 15, 2026Bought 1,000 shares at $10.58 of Keros Therapeutics, Inc.²⁷
• Apr 15, 2026Bought 1,000 shares at $11.70 of Keros Therapeutics, Inc.²⁸
• Mar 11, 2026Bought 1,000 shares at $21.55 of Immunome Inc.²⁹
• Mar 10, 2026Bought 1,000 shares at $22.12 of Immunome Inc.²⁹
• Mar 9, 2026Bought 2,000 shares at $11.21 of Keros Therapeutics, Inc.³⁰